Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician's choice systemic therapy in patients with breast cancer brain metastases Meeting Abstract
| Authors: | Shen, C.; Abdou, Y.; Chen, L.; Tan, X.; Gupta, G. P.; Lynce, F.; Lobbous, M.; Stringer-Reasor, E. M.; Anders, C. K. |
| Abstract Title: | Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician's choice systemic therapy in patients with breast cancer brain metastases |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.TPS1133 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: TPS1133 -- Meeting was also available virtually -- Source: Cinahl |
